Iovance Biotherapeutics shares owned by Citadel Advisors
Quarter-by-quarter ownership of Iovance Biotherapeutics (IOVA) shares owned by Citadel Advisors
from 13F filings
Historical chart of Citadel Advisors investment in Iovance Biotherapeutics
Tip: Access up to 7 years of quarterly data
All positions including Iovance Biotherapeutics held by Citadel Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csvQuarterly reported holdings in Iovance Biotherapeutics by Citadel Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $11M | 5.1M | 2.17 |
| 2025-06-30 | $8.8M | 5.1M | 1.72 |
| 2025-03-31 | $9.0M | 2.7M | 3.33 |
| 2024-12-31 | $19M | 2.5M | 7.40 |
| 2024-09-30 | $19M | 2.0M | 9.39 |
| 2024-06-30 | $7.8M | 979k | 8.02 |
| 2024-03-31 | $31M | 2.1M | 14.82 |
| 2023-12-31 | $8.2M | 1.0M | 8.13 |
| 2023-09-30 | $5.8M | 1.3M | 4.55 |
| 2023-06-30 | $13M | 1.8M | 7.04 |
| 2023-03-31 | $24M | 3.9M | 6.11 |
| 2022-12-31 | $17M | 2.6M | 6.39 |
| 2022-06-30 | $32M | 2.9M | 11.04 |
| 2022-03-31 | $13M | 773k | 16.65 |
| 2021-12-31 | $13M | 659k | 19.09 |
| 2021-09-30 | $44M | 1.8M | 24.66 |
| 2021-06-30 | $72M | 2.8M | 26.02 |
| 2021-03-31 | $34M | 1.1M | 31.66 |
| 2020-12-31 | $78M | 1.7M | 46.40 |
| 2020-09-30 | $47M | 1.4M | 32.92 |
| 2020-06-30 | $58M | 2.1M | 27.45 |
| 2020-03-31 | $16M | 549k | 29.94 |
| 2019-12-31 | $15M | 547k | 27.75 |
| 2019-09-30 | $9.3M | 513k | 18.13 |
| 2019-06-30 | $14M | 589k | 24.52 |
| 2019-03-31 | $18M | 1.9M | 9.51 |
| 2018-12-31 | $40M | 4.5M | 8.85 |
| 2018-09-30 | $38M | 3.4M | 11.34 |
| 2018-06-30 | $6.4M | 503k | 12.81 |
| 2018-03-31 | $4.0M | 235k | 16.92 |
| 2017-12-31 | $346k | 43k | 8.03 |
| 2017-09-30 | $513k | 66k | 7.75 |